Hosted by John Cumbers · 🇺🇸 US · EN · 27 episodes
Established thought leaders with verified media credentials.
Welcome to The SynBioBeta Podcast: Conversations with synthetic biology’s leading thinkers on building a better world with biology. Hosted by John Cumbers, founder and CEO of SynBioBeta, where tech meets bio and bio meets tech. Stay updated on the latest news in synthetic biology , check out our weekly newsletter and follow us on social media: Twitter | LinkedIn | Facebook
John Cumbers hosts The SynBioBeta Podcast, a science show with 27 episodes published.
In this episode of the Podcast, SynBioBeta founder and CEO, John Cumbers, speaks with Harshal Chokhawala , co-founder and CEO of ZymoChem , about how the company is reengineering the foundations of materials science usin
In this episode of the SynBioBeta Podcast, John Cumbers sits down with Shannon Hall, co-founder and CEO of Pow.bio , to talk about how her team is flipping traditional fermentation on its head. Pow.bio’s AI-enabled, cont
In this episode, John Cumbers speaks with Harshal Chokhawala , co-founder and CEO of ZymoChem , about how the company is reengineering the foundations of materials science using microbial fermentation. Harshal discusses
On this SynBioBeta podcast, John Cumbers talks with Edward Shenderovich, the Founder and CEO of Synonym, a company creating bioeconomy infrastructure to help next-generation bioproducts scale and get to market. Edward wi
On this SynBioBeta podcast, John Cumbers talks with Eben Bayer, the CEO of Ecovative, a pioneering company at the forefront of developing sustainable materials using mycelium. John and Eben will discuss Ecovative’s journ
On this SynBioBeta podcast, John Cumbers talks with Sean McClain, founder, and CEO of Absci, a generative AI drug creation company on a mission to create better drugs for patients faster. Sean and John will continue some
Today, John Cumbers talks with Ursheet Parikh, a general partner at Mayfield Fund, an early-stage, global venture capital firm with a people-first philosophy and a 50-plus-year history of investing and partnering with fo
Today John Cumbers talks with Kyle Giffin, Co-Founder and COO of Latch Bio, the San Francisco-based company that is looking to harmonize data analysis through the application of its integrated bioinformatics platform. Ov
In this episode, John Cumbers chats with Michael Kamdar, President & CEO and Phil Paik, CTO, both of whom are at Molecular Assemblies—a San Diego-based life sciences company developing an enzymatic DNA synthesis technolo
Today John Cumbers talks with Claire Aldridge, Chief Strategy Officer at FormBio. Together they will discuss Form Bio, the spin-out from Colossal Laboratories & Biosciences, cell and gene therapies, why they are so diffi
Today John Cumbers talks with Jason Kelly, Co-founder and CEO of Ginkgo Bioworks. Together they will discuss synthetic biology’s coming of age” and get Jason’s take on several topics, such as the history of programmable
Today John Cumbers talks with Matt Ocko, co-founder and co-Managing Partner of the silicon valley deep tech venture fund DCVC. The topics for today are the different visions of the Star Trek and Star Wars future economie
Today John Cumbers talks with Massimo Portincaso, managing director and partner at BCG. John will be talking to Massimo about what nature co-design, how we're shifting from global supply chains to global value chains, wh
Today John Cumbers talks with Karl Schmieder the founder of messagingLAB, a strategy and consulting firm that helps biotechnology and synthetic biology companies create and execute strategies to drive the industry forwar
Today John Cumbers talks with Ryan Bethencourt, founder and CEO of Wild Earth. John will be talking to Ryan about the state of COVID and questions like "Does eating animals cause pandemics?" Recorded live on: March 15th,
Today John Cumbers talks with Emily Leproust, Entrepreneur and CEO of Twist Bioscience. John will be talking to Emily about why she founded Twist, the many industries that will be disrupted by DNA technology, and how Twi
Today John Cumbers talks with John Nicols, President and CEO of Codexis, a leading protein engineering company here in Silicon Valley. I’ll be talking with John about “How protein engineering is the killer app for biolog
Today John Cumbers talks with D.A. Wallach, recording artist and emerging tech investor. John will be talking to D.A. about his journey from performing artist to investor in emerging tech, how his unique background infor
Today John Cumbers talks with Tom Dierking, design director of transformational platform technologies at Procter & Gamble. John will be talking to Tom about his passion for transforming the consumer experience, Procter &
For the pictures John and Eben reference check out our website article (https://synbiobeta.com/synbiobeta-podcast-the-mycelium-revolution/) Today John Cumbers talks with Eben Bayer, CEO and Co-Founder of the biomaterials
Detected from recent episode content. Sponsor presence is a real signal of listener purchasing power and show monetisation.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
The SynBioBeta Podcast has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
The SynBioBeta Podcast is hosted by John Cumbers. The show is categorised under science (business) and has published 27 episodes.
The SynBioBeta Podcast has published 27 episodes.
The SynBioBeta Podcast regularly covers science, business, investing. It sits in the science category, with a business focus.
The SynBioBeta Podcast is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
The SynBioBeta Podcast hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of The SynBioBeta Podcast average 50 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates The SynBioBeta Podcast's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 10 days ago.
